![](https://d3ilqtpdwi981i.cloudfront.net/AFK8YdTBkWvUpe5fx8ywg6B5oMo=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/20/53/68/20536828-1ca8-462c-b6c2-044d25b7b114/file.png)
Article
ACTR-33. A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER
Neuro-oncology
(2017)
Disciplines
Publication Date
November 6, 2017
DOI
10.1093/neuonc/nox168.026
Citation Information
Tiffany Juarez, Najee Boucher, Annie Heng, Jaya Gill, et al.. "ACTR-33. A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER" Neuro-oncology Vol. 19 (2017) Available at: http://works.bepress.com/marlon-saria/11/